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У роботі наведені сучасні дані зарубіжної літератури, які стосуються синдрому Гудпасчера – імунно-запальної па-
тології, що характеризується утворенням аутоантитіл до базальних мембран ниркових клубочків і легеневих аль-
веол, і виявляється геморагічним пневмонітом в поєднанні з легеневою кровотечею (кровохарканням) та гломе-
рулонефритом. Етіологічні механізми захворювання достовірно не визначені. Клінічні спостереження вказують на 
зв'язок розвитку синдрому Гудпасчера з перенесеною вірусною інфекцією, прийомом лікарських препаратів, ви-
робничою шкодою. Частота розвитку синдрому Гудпасчера становить 1 випадок на 1 млн. населення. У зв'язку з 
рідкістю даної патології кожен випадок синдрому Гудпасчера представляє великий теоретичний і практичний ін-
терес. Проведений аналіз власного клініко-морфологічного випадку синдрому Гудпасчера. При проведенні пато-
логоанатомічного дослідження тіла померлого виявлені морфологічні ознаки, що свідчать про наявність при житті 
синдрому Гудпасчера, основними проявами якого слід вважати геморагічний пневмоніт і мезангіо-
проліферативний гломерулонефрит з подальшою фібропластичною трансформацією клубочків. В даному випадку 
безпосередньою причиною смерті слід вважати гостру легенево-серцеву недостатність, так як патоморфологічні 
зміни в легенях превалювали над такими в нирках, що повністю відповідає клінічній картині та результатам лабо-
раторних досліджень. Певний інтерес даний випадок представляє також в сенсі грамотного формулювання оста-
точного діагнозу, так як можна говорити про поєднання двох захворювань: синдрому Гудпасчера і гострого флег-
монозного апендициту з місцевим перитонітом. Постановка діагнозу синдрому Гудпасчера в клініці не завжди 
буває своєчасним, свідчить про важкий стан пацієнта, вимагає ретельної диференціальної діагностики з рядом 
інших захворювань, що супроводжуються геморагічним легенево-нирковим синдромом, і потребує невідкладного 
призначення активної терапії імуносупресорами, включаючи преднізолон і цитостатики. Вчасно розпочате адек-
ватне лікування значно покращує прогноз пацієнтів. 
Ключові слова: синдром Гудпасчера, гломерулонефрит, геморагічний пневмоніт, флегмонозний апендицит, ле-
генева кровотеча. 
The Goodpasture syndrome is an immune-inflammatory pathology characterized by the formation of autoantibodies 
directed against the basement membranes of the renal glomeruli and pulmonary alveoli, manifested by hemorrhagic 
pneumonitis in combination with pulmonary hemorrhage (hemoptysis) and glomerulonephritis. To date, etiological 
mechanisms of the disease are unknown. Clinical observations indicate a relationship between the development of 
Goodpasture syndrome and viral infection, intake of medications, industrial hazards. The incidence of Goodpasture 
syndrome is estimated to be 1 case per 1 million population. Due to the rarity of this pathology, each case of Goodpasture 
syndrome is of great theoretical and practical interest. The authors conducted the analysis of clinical and morphological 
observation of Goodpasture syndrome. The postmortem study revealed morphological signs indicating the presence of 
Goodpasture syndrome inter vivos, whose main manifestations were hemorrhagic pneumonitis and mesangial-proliferative 
glomerulonephritis with fibroplastic transformation. The reported case is also of particular interest in terms of correct 
formulation of the final diagnosis, since there was a combination of two diseases: Goodpasture syndrome and phlegmonous 
appendicitis with focal peritonitis. In this case, pulmonary heart failure should be considered as the direct cause of death, 
since pulmonary lesions prevailed over the renal ones, which is fully consistent with the clinical presentation and findings of 
the laboratory tests. The diagnosis of Goodpasture syndrome made at the hospital is not always timely, as can be 
evidenced by patient’s severe condition, and it requires careful differentiation with a number of other diseases involving 
hemorrhagic pulmonary and renal syndrome, and the urgent need for active therapy with immunosuppressants, including 
prednisone and cytostatics. The timely adequate treatment significantly improves the prognosis. 
Keywords: Goodpasture syndrome, glomerulonephritis, hemorrhagic pneumonitis, phlegmonous appendicitis, 
pulmonary hemorrhage.. 
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Goodpasture syndrome (GPS) is an immune-
inflammatory pathology characterized by the formation of 
autoantibodies directed against the basement mem-
branes of the renal glomeruli and pulmonary alveoli, 
manifested by hemorrhagic pneumonitis in combination 
with pulmonary hemorrhage (hemoptysis) and glomeru-
lonephritis [2, 3].  
The disease was first described by an American phy-
sician and pathophysiologist E.W. Goodpasture (1886–
1960) during the influenza epidemic in 1919 in the 18-
year-old young man who developed kidney damage in 
the form of nephritis and pneumonia, followed by hemop-
tysis within one month after suffering flu [8]. The inci-
dence of Goodpasture syndrome is estimated to be 1 
case per 1 million population. There are two age peaks of 
incidence: at the age of 20-30 years and 50-60 years; it 
occurs more commonly in males [5, 9]. If untreated, mor-
tality among patients reaches 75–90% [17]. Due to the 
rarity of this pathology, each case of Goodpasture syn-
drome is of great theoretical and practical interest. [5, 9]. 
Etiological mechanisms of the disease are unknown. 
Clinical observations indicate a relationship between the 
development of Goodpasture syndrome and viral infec-
tion (influenza, Viral Hepatitis A, etc.), intake of medica-
tions (carbimazole, penicillamine), industrial hazards (in-
halation of organic solvent vapors, varnishes, gasoline), 
hypothermia, smoking [4 ]. Genetic susceptibility to this 
syndrome has been noted in individuals-carriers of HLA-
DRwl5, HLA-DR4 and HLA-DRB1 alleles. Family cases 
of Goodpasture syndrome have been also described. 
Under the influence of one or another etiological fac-
tor, as a result of changes in the tolerance of the im-
mune system, the body begins to produce autoantibod-
ies directed against the basement membranes of the 
pulmonary alveoli and the renal glomeruli [6]. It is hy-
pothesized that the structural component (NC-1) a-3 of 
type IV collagen chains, which is present in the base-
ment membranes of the pulmonary and renal capillar-
ies, plays the role of an autoantigen. Formed antibodies 
against the components of the basement membranes of 
the alveoli and renal glomeruli (anti-GBM antibodies) in 
the presence of C3-complement bind to antigens; the 
resulting immune complexes are deposited along the 
basement membranes, inducing immuno-inflammatory 
damage to the renal glomeruli (glomerulonephritis) and 
pulmonary alveoli (alveolitis) [7, 9, 11]. In the develop-
ment of autoimmune inflammation, activation of cellular 
elements (T-lymphocytes, endotheliocytes, monocytes, 
alveolar macrophages, polymorphonuclear leukocytes), 
cytokines (insulin-like, platelet growth factors, tumor ne-
crosis factors, interleukin-1),  free radicals, proteolytic 
enzymes, adhesive molecules and other factors damag-
ing renal tissue, play a significant role [10].  In the de-
velopment of alveolitis in Goodpasture syndrome, acti-
vation of alveolar macrophages is of great importance. 
In the activated state, they release about 40 cytokines. 
Type I cytokines (chemotaxins, leukotrienes, interleukin-
8) enhance the entry of polymorphonuclear leukocytes 
into the lungs. Type II cytokines (platelet, macrophage 
growth factors) promote transfer of fibroblasts into the 
lungs. Alveolar macrophages also produce reactive 
oxygen species, proteases, that damage pulmonary tis-
sue. 
The pathomorphological manifestations of Goodpas-
ture syndrome are hemorrhagic necrotizing alveolitis and 
nephrosonephritis. Histological study of renal tissue re-
veals proliferative-membranous, proliferative or necrotiz-
ing glomerulonephritis, glomerular sclerosis, and renal 
parenchyma fibrosis. Morphological study of pulmonary 
tissue reveals capillary disease with pronounced destruc-
tion and proliferation phenomena of predominantly inter-
alveolar septa, alveolitis with hemorrhagic exudate into 
the alveoli, pulmonary infiltrates, hemosiderosis, pneu-
mosclerosis [1].   
Three variants of the clinical course of the Goodpas-
ture syndrome are distinguished: malignant (which is 
characterized by recurrent hemorrhagic pneumonia and 
rapidly progressive glomerulonephritis), moderate (with a 
slower development of lesions in the kidneys and lungs) 
and slow (with prevailing phenomena of glomerulonephri-
tis and chronic renal failure and late development of pul-
monary manifestations) [17].  
The most sensitive and specific method for diagnos-
ing Goodpasture syndrome is the determination of serum 
antibodies against glomerular basement membrane (Anti-
GBM) by indirect immunofluorescence technique or, if 
available, enzyme-linked immunosorbent assay (ELISA) 
with recombinant or human NC-1α-3 (in the highest con-
centrations it is found in the basement membranes of the 
renal and pulmonary capillaries). The presence of these 
antibodies confirms the diagnosis [12]. In case when anti-
GBM antibodies are not detected, though symptoms of 
glomerulonephritis (hematuria, proteinuria, urinary red 
blood cells casts, kidney failure, or a combination of 
these symptoms) are present, a kidney biopsy is indi-
cated to confirm the diagnosis. Immunofluorescence 
staining of the renal or pulmonary tissue classically detects 
linear deposition of IgG along glomerular or alveolar capillar-
ies [16]. Similar changes can also occur in diabetic neph-
ropathy and fibrillar glomerulonephritis, a rare disease caus-
ing pulmonary-renal syndrome, but the fixation of antibodies 
to the glomerular basement membrane in these diseases is 
nonspecific and does not occur linearly. 
The clinical course of Goodpasture syndrome is 
steadily progressive; the prognosis is unfavorable. Gen-
erally, patients die due to massive pulmonary hemor-
rhages, severe renal or pulmonary failure. It is believed 
that high levels of serum creatinine, oligoanuria, the ab-
sence of normal glomeruli and a high percentage of de-
milunes in the kidney biopsy, and the circulation of anti-
bodies to the glomerular basement membrane in high 
titre determine the severity of the clinical course of the 
disease [15]. The survival rate of patients from the onset 
of the disease varies from a few months to 1-3 years.   
We report a lethal case of GPS combined with the 
acute appendicitis and subsequent postmortem verifica-
tion. 
The 22-year old patient L. was referred to Nephrology 
Unit at the Regional Clinical Hospital from the Central 
District Hospital.  
It is known from the history that the patient suffered 
from edema of lower extremities, headache and elevated 
blood pressure (160/90 mmHg) during the last five 
months.  During the last month, he complained of wors-
ening of the general state of health and was admitted to 
the Therapeutic Unit at the Central District Hospital in the 
place of residence. The patient was examined clinically, 
laboratory and instrumentally. Complete blood count 
showed: WBC 7,5х109/L L 7.5x109 / l, RBC 3,4х1012/L, 
hemoglobin 106 g / L, ESR 19 mm/h, eosin. 0%, stab7%, 
segment.80%, lymphocytes 11%, monocytes 2%. Uri-
nalyses showed: protein 1.47 g/l, WBCs 4-5 per power 
field, RBCs 25-30 per power field. Biochemical blood test 
showed: total bilirubin 14.7 μmol/L, direct bilirubin 4.2 
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μmol/L, indirect bilirubin 10.5 μmol/ L, urea 14.7 mmol/L, 
creatinine 293 μmol/L, total protein 59 g/L, prothrombin 
index 86%, fibrinogen 3.55 g/L.   
Based on the resulting data, the diagnosis was made: 
the acute glomerulonephritis with stage 2 acute renal 
failure. Mild anemia. Stage 2 arterial hypertension of the 
second degree, risk ІІ. Uremic pneumonitis is uncertain. 
Right kidney cyst.  
Within 3 days in a state of moderate severity, with 
complaints of severe general weakness, shortness of 
breath, dizziness with changes of body posture, nausea, 
edema of lower extremities, elevated blood pressure to 
200/100 mm Hg the patient was transferred to the Ne-
phrology Unit at the Regional Clinical Hospital to clarify 
the diagnosis and follow-up treatment. 
On the fifth day of the in-patient treatment, the patient 
suddenly complained of severe pain in the right inguinal 
region, and after consultation with a surgeon, a diagnosis 
was made: acute appendicitis, which was followed by 
appendectomy, with subsequent sanation and drainage 
of the abdominal cavity.  
After surgery, the patient’s condition remained se-
vere; there were complaints of general weakness, dizzi-
ness, hemoptysis. Chest CT revealed signs of bilateral 
infiltration of the lung tissue, bilateral hydrothorax, and 
lymphadenopathy.  
Based on clinical, laboratory and instrumental findings 
(hemoptysis, shortness of breath, symptoms characteris-
tic of glomerular lesions of the kidneys, uremia, chest X-
ray and CT), a clinical diagnosis was made: glomeru-
lonephritis, urinary syndrome, severe course, CRF III. 
Arterial hypertension stage II, grade 3, high risk. Good-
pasture syndrome (alveolitis, pulmonary hemorrhage). 
Secondary hypochromic and severe post-hemorrhagic 
anemia. Acute phlegmonous appendicitis, local serous 
peritonitis.  
Despite continued therapeutic medical care, the pa-
tient’s condition rapidly deteriorated due to progressive 
cardiovascular insufficiency and on day 2 thereafter the 
patient died.  
The autopsy revealed morphological signs indicating 
the presence of GPS inter vivos, the main manifestations 
were hemorrhagic pneumonitis and mesangial-prolife-
rative glomerulonephritis with fibroplastic transformation.  
Thus, the lungs, while maintaining normal size, were 
diffusely compacted in all parts, dark red on the surface 
and in the section (Fig. 1). 
 
Fig.1 Macroscopic view of the left lung. 
Microscopic study revealed that in the lung tissue of 
its almost all parts, the alveoli were filled with blood, with 
the presence of hemolyzed erythrocytes, focal aggrega-
tions of hemosiderophages. This fact gives evidence of 
old long-term intra-alveolar hemorrhages. In some places 
in the alveoli hydropic fluid was found, the interalveolar 
septa were markedly thickened with blood microvessels 
with thickened and loosened walls, proliferation of the 
endothelium (Fig. 2). 
 
Fig .2 Microscopic view of the lung  
H&E stain,150× magnification.  
1 – alveoli filled with blood, 2 – thickened interalveolar septa. 
Dimensions of the kidneys did not have significant 
deviations from the norm and were: right kidney : 11x6x5 
cm, left kidney: 11x5.5x4.5 cm. The surface of the kid-
neys was smooth, pale brown, with multiple red dots. On 
the section the tissue was rather dense, pale brown, the 
layers were not clearly differentiated. The cortex was col-
ored pale brown with multiple red dots; the renal pyra-
mids were pink-brown. The pelves and calyces were not 
dilated, filled with a yellowish transparent fluid; their mu-
cous membrane was pale gray and smooth.  
Microscopic study of the kidneys showed that most of 
the capillary glomeruli were enlarged with significant in-
crease in the number of cellular elements, mainly due to 
mesangiocytes, depletion and narrowing of the capillary 
lumen; the glomerular capsules were markedly thickened 
(Fig. 3).  
 
Fig.3 Microscopic view of the lung 
. H&E stain,  600× magnification.  
At the same time, in both kidneys, glomeruli with vary-
ing degrees of fibroblastic transformation were constantly 
noted, the initial stages of which were manifested by the 
moderate atrophy and sclerosis, and terminal ones with 
hyalinosis. In the renal interstitium a diffuse and small-
focal inflammatory infiltration was detected, represented 
mainly by lymphocytes and plasma cells. Heterogeneous 
blood filling was characteristic for blood vessels (Fig. 4).  
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Fig.4 Microscopic view of the lung. 
 Van-Gieson stain, 400 × magnification. 
Capillary glomeruli with varying degrees of fibroblastic 
transformation, in the interstitium - diffuse inflammatory 
infiltration. 
In the epithelial cells of the renal tubules, lesions, 
characteristic of hydropic dystrophy, were noted; some-
times we observed the development of total necrosis, as 
evidenced by the destroyed and partially lysed nuclei of 
nephrocytes.  
In the other internal organs, nonspecific changes 
characteristic of intoxication and progressive pulmonary 
heart failure were detected. 
On the basis of the combination of the lesions listed 
above, the final combined (bi-causal) postmortem diag-
nosis was made: Underlying diseases: 1. Goodpasture 
syndrome, mesangial-proliferative glomerulonephritis, 
hemorrhagic pneumonitis. 2 Phlegmonous appendicitis 
with local serous peritonitis. Surgery: appendectomy, 
drainage of the abdominal cavity. Complications of the 
underlying diseases: Hydrothorax: 500 ml on the left, 300 
ml on the right. Anemia, parenchymal dystrophy of inter-
nal organs, focal pulmonary edema, brain edema. 
This case is also of particular interest in terms of cor-
rect formulation of the final diagnosis, since it was noted 
above that there was a combination of two diseases: 
GPS and phlegmonous appendicitis with focal peritonitis. 
Most likely, in this case, phlegmonous appendicitis, not 
conjoint with GPS, could not lead to death of the patient, 
considering the promptly performed surgical intervention 
without complications. At the same time, it cannot be de-
nied that the presence of phlegmonous appendicitis, the 
surgery (performed according to vital signs) aggravated 
the severity of the patient’s state of health and acceler-
ated the lethal outcome.  
Thus, in the reported case, there are two, mutually 
complicating (combined) underlying diseases, described 
in the postmortem diagnosis [13, 14]. In this case, pul-
monary heart failure should be considered as the direct 
cause of death, since pulmonary lesions prevailed over 
the renal ones, which is fully consistent with the clinical 
picture and findings of the laboratory tests.  
The diagnosis of GPS made at the hospital is not al-
ways timely, as can be evidenced by patient’s severe 
condition, and it requires careful differentiation with a 
number of other diseases involving hemorrhagic pulmo-
nary-renal syndrome, and the urgent need for active 
therapy with immunosuppressants, including prednisone 
and cytostatics. Timely adequate treatment significantly 
improves the prognosis. 
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